Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cohort Study Evaluating the Clinical Effectiveness, Safety and Immunogenicity to the Pandemic Influenza Vaccination (MUCOFLU)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT01499914
First received: November 21, 2011
Last updated: August 25, 2014
Last verified: August 2014